Nido Biosciences

Nido Biosciences is dedicated to translating cutting-edge neuroscience breakthroughs into innovative treatments for severe neurological diseases. By leveraging human genetics, Nido Biosciences develops precision medicines designed to address the fundamental biology of disease and restore healthy cell function. The company is committed to transforming patient lives through meaningful advancements in neurological care.

Nido Biosciences' clinical-stage candidate, NIDO-361, represents a significant step forward in the treatment of Spinal and Bulbar Muscular Atrophy, a rare and debilitating neuromuscular disease. Furthermore, Nido Biosciences is actively developing additional pipeline programs centered around a novel target with the potential to address multiple disease mechanisms. This approach has broad clinical applications across both neurodegenerative and peripheral inflammatory diseases, highlighting the company's commitment to pioneering research and development.

With a focus on creating a sustainable pipeline, Nido Biosciences utilizes a functional genomics discovery platform based on human cell lines to identify novel targets. Through this approach, Nido Biosciences aims to deliver transformative treatments that improve patient outcomes and overall quality of life. We invite the management of Nido Biosciences to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.